What potential is there for LSD1 inhibitors to reach approval for AML?

被引：16
|
作者：
Pandey, Manu R. [1 ]
Wang, Eunice S. [1 ]
机构：
[1] Roswell Park Comprehens Canc Ctr, Dept Med, Leukemia Serv, Elm & Carlton St, Buffalo, NY 14263 USA
来源：
EXPERT OPINION ON EMERGING DRUGS | 2019年 / 24卷 / 04期
关键词：
LSD1; inhibitor; epigenetic; acute myeloid leukemia; clinical trial; HISTONE DEMETHYLASE; DIFFERENTIATION; LEUKEMIA; EPIGENETICS; COMBINATION; DERIVATIVES; THERAPY; DESIGN; GROWTH;
D O I：
10.1080/14728214.2019.1694001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：205 / 212
页数：8
相关论文
共 50 条
  • [1] Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia
    Przespolewski, Amanda
    Wang, Eunice S.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (07) : 771 - 780
  • [2] Discovery of reversible LSD1 inhibitors
    Kanouni, Toufike
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [3] A comprehensive comparative study on LSD1 in different cancers and tumor specific LSD1 inhibitors
    Dong, Jianshu
    Pervaiz, Waqar
    Tayyab, Bilal
    Li, Die
    Kang, Lei
    Zhang, Huimin
    Gong, Huimin
    Ma, Xinli
    Li, Jian
    Agboyibor, Clement
    Bi, Yuefeng
    Liu, Hongmin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 240
  • [4] Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1
    Dai, Xing-Jie
    Liu, Ying
    Xue, Lei-Peng
    Xiong, Xiao-Peng
    Zhou, Ying
    Zheng, Yi-Chao
    Liu, Hong-Min
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (05) : 2466 - 2488
  • [5] Design, synthesis and in vitro evaluation of stilbene derivatives as novel LSD1 inhibitors for AML therapy
    Duan, Yingchao
    Qin, Wenping
    Suo, Fengzhi
    Zhai, Xiaoyu
    Guan, Yuanyuan
    Wang, Xiaojuan
    Zheng, Yichao
    Liu, Hongmin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (23-24) : 6000 - 6014
  • [6] Antitumor activity of novel reversible LSD1 inhibitors in preclinical models of AML and SCLC.
    Byun, Joo-Yun
    Lee, Won Jong
    Kim, Won jung
    Kim, Minjeong
    Bae, Inhwan
    Hong, Seokhyun
    Kim, Yu-Yon
    Park, Hyunjin
    Kim, Eunyoung
    Kim, Young Hoon
    Ahn, Young Gil
    Suh, Kwee Hyun
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors
    Gehling, Victor S.
    Mcgrath, John P.
    Duplessis, Martin
    Khanna, Avinash
    Brucelle, Francois
    Vaswani, Rishi G.
    Cote, Alexandre
    Stuckey, Jacob
    Watson, Venita
    Cummings, Richard T.
    Balasubramanian, Srividya
    Iyer, Priya
    Sawant, Priyanka
    Good, Andrew C.
    Albrecht, Brian K.
    Harmange, Jean-Christophe
    Audia, James E.
    Bellon, Steven F.
    Trojer, Patrick
    Levell, Julian R.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (06): : 1213 - 1220
  • [8] Dual inhibitors of LSD1 and spermine oxidase
    Holshouser, Steven
    Dunworth, Matthew
    Murray-Stewart, Tracy
    Peterson, Yuri K.
    Burger, Pieter
    Kirkpatrick, Joy
    Chen, Huan-Huan
    Casero, Robert A., Jr.
    Woster, Patrick M.
    MEDCHEMCOMM, 2019, 10 (05) : 778 - 790
  • [9] Discovery of potent reversible inhibitors of LSD1
    Chen, Young
    Kanouni, Toufike
    Severin, Christophe
    Xu, Jiangchun
    Del Rosario, Joselyn
    Shi, Lihong
    Lai, Chon
    Stafford, Jeffrey
    Veal, Jim
    Stansfield, Ryan
    Cho, Rob
    Yuen, Natalie
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [10] Design and identification of two novel resveratrol derivatives as potential LSD1 inhibitors
    Xu, Yongtao
    Gao, Yunlong
    Yang, Min
    Wang, Meiting
    Lu, Jiarui
    Wu, Ziqing
    Zhao, Junqiang
    Yu, Yi
    Wang, Chang
    Zhao, Zongya
    Gao, Qinghe
    Duan, Yingchao
    Han, Di
    FUTURE MEDICINAL CHEMISTRY, 2021, 13 (17) : 1415 - 1433
12345